Daniel R Mishell
Biographic Data
| ID | 5991093 |
|---|---|
| NAME | Daniel R Mishell |
| GIVEN NAMES | Daniel R |
| FAMILY NAME | Mishell |
| SIGNATURE | MISHELL D R |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1982 |
| LATEST PUBLICATION YEAR | 1996 |
| H-INDEX | 0 |
Performance of the TCu380A and Cu-Fix IUDs in an International Randomized Trial
To compare the clinical performance of the TCu380A, the most widely used copper IUD in the world today, and a new frameless device, the Cu-Fix, we report results from a randomized international two-year clinical trial involving 874 parous women followed for an average of fourteen months. Event rates at the end of two years (per 100 women) for pregnancy were 0.0 for the TCu380A and 1.5 for the Cu-Fix. Termination due to expulsion was significantly…
The Acceptability of a Combined Oestrogen/Progestogen Contraceptive Vaginal Ring
The acceptability of a vaginal ring releasing ethinyl oestradiol 20 mcg per day and norethindrone acetate 1 mg per day was assessed during a six-month phase II trial comparing three different regimens, which was carried out simultaneously in Los Angeles and Sydney. Sixty women were enrolled in Sydney and 90 in Los Angeles. On admission into the study, the women were asked to complete a questionnaire which gave details of age, last contraceptive m…
Early Abortion with a Single Dose of the Antiprogestin RU-486
RU-486 is a synthetic progesterone antagonist that is abortifacient in early pregnancy. This trial evaluated the effectiveness and safety of a single 600 mg oral dose given to 50 healthy women ≤49 days from their last menstrual period. Efficacy was inversely related to the initial β-subunit of human chorionic gonadotropin level; ranging from 100% at 20,000 mlU/ml (p
Recovery of Fertility After Use of the Levonorgestrel 20 mcg/day or Copper T 380 Ag Intrauterine Device
Advances in Fertility Research, Volume 1
No prominent works on this page.
Advances in Fertility Research, Volume 1
Recovery of Fertility After Use of the Levonorgestrel 20 mcg/day or Copper T 380 Ag Intrauterine Device
Early Abortion with a Single Dose of the Antiprogestin RU-486
RU-486 is a synthetic progesterone antagonist that is abortifacient in early pregnancy. This trial evaluated the effectiveness and safety of a single 600 mg oral dose given to 50 healthy women ≤49 days from their last menstrual period. Efficacy was inversely related to the initial β-subunit of human chorionic gonadotropin level; ranging from 100% at 20,000 mlU/ml (p
The Acceptability of a Combined Oestrogen/Progestogen Contraceptive Vaginal Ring
The acceptability of a vaginal ring releasing ethinyl oestradiol 20 mcg per day and norethindrone acetate 1 mg per day was assessed during a six-month phase II trial comparing three different regimens, which was carried out simultaneously in Los Angeles and Sydney. Sixty women were enrolled in Sydney and 90 in Los Angeles. On admission into the study, the women were asked to complete a questionnaire which gave details of age, last contraceptive m…
Performance of the TCu380A and Cu-Fix IUDs in an International Randomized Trial
To compare the clinical performance of the TCu380A, the most widely used copper IUD in the world today, and a new frameless device, the Cu-Fix, we report results from a randomized international two-year clinical trial involving 874 parous women followed for an average of fourteen months. Event rates at the end of two years (per 100 women) for pregnancy were 0.0 for the TCu380A and 1.5 for the Cu-Fix. Termination due to expulsion was significantly…
Medicine (4 works) · Gynecology (3 works) · Obstetrics (3 works) · Population (3 works) · Reproductive Health and Contraception (3 works) · Assisted Reproductive Technology and Twin Pregnancy (2 works) · Environmental health (2 works) · Family planning (2 works) · Fertility (2 works) · Pregnancy and Medication Impact (2 works)